A Novel 3-Dimensional Co-culture Method Reveals a Partial Mesenchymal to Epithelial Transition in Breast Cancer Cells Induced by Adipocytes.


Journal

Journal of mammary gland biology and neoplasia
ISSN: 1573-7039
Titre abrégé: J Mammary Gland Biol Neoplasia
Pays: United States
ID NLM: 9601804

Informations de publication

Date de publication:
03 2019
Historique:
received: 28 06 2018
accepted: 02 11 2018
pubmed: 27 11 2018
medline: 22 7 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Cancer metastases are accountable for almost 90% of all human cancer related deaths including from breast cancer (BC). Adipocytes can alter the tumor microenvironment, which can promote metastasis by inducing an epithelial-to-mesenchymal transition (EMT) in BC cells. However, the role of adipocytes during the mesenchymal-to-epithelial transition (MET), that can be important in metastasis, is not clear. To understand the effect of adipocytes on the BC progression, there is a requirement for a better in vitro 3-dimensional (3D) co-culture system that mimics the breast tissue and allows for more accurate analysis of EMT and MET. We developed a co-culture system to analyze the relationship of BC cells grown in a 3D culture with adipocytes. We found that adipocytes and adipocyte-derived conditioned media, but not pre-adipocytes, caused the mesenchymal MDA-MB-231 and Hs578t cells to form significantly more epithelial-like structures when compared to the typical stellate colonies formed in control 3D cultures. SUM159 cells and MCF7 cells had a less dramatic shift as they normally have more epithelial-like structure in 3D culture. Biomarker expression analysis revealed that adipocytes only induced a partial MET with proliferation unaffected. In addition, adipocytes had reduced lipid droplet size when co-cultured with BC cells. Thus, we found that physical interaction with adipocytes and ECM changes the mesenchymal phenotype of BC cells in a manner that could promote secondary tumor formation.

Identifiants

pubmed: 30474817
doi: 10.1007/s10911-018-9420-4
pii: 10.1007/s10911-018-9420-4
doi:

Substances chimiques

Biomarkers, Tumor 0
Culture Media, Conditioned 0
Extracellular Matrix Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

85-97

Références

Methods. 2003 Jul;30(3):256-68
pubmed: 12798140
Cancer Res. 2004 Dec 1;64(23):8694-701
pubmed: 15574779
Nat Methods. 2007 Apr;4(4):359-65
pubmed: 17396127
Mol Oncol. 2007 Jun;1(1):84-96
pubmed: 18516279
Science. 2011 Mar 25;331(6024):1559-64
pubmed: 21436443
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
Breast Cancer Res. 2011;13(6):227
pubmed: 22078026
Mol Carcinog. 2013 Mar;52(3):167-82
pubmed: 22162252
J Vis Exp. 2012 Apr 30;(62):null
pubmed: 22566026
Int J Cancer. 2013 Jan 15;132(2):288-96
pubmed: 22696278
J Cell Sci. 2012 Jul 1;125(Pt 13):3015-24
pubmed: 22797912
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Breast Cancer Res Treat. 2013 Jan;137(1):307-14
pubmed: 23179600
Int J Breast Cancer. 2013;2013:872743
pubmed: 23401782
PLoS One. 2013;8(3):e59689
pubmed: 23555746
Leuk Lymphoma. 2014 Feb;55(2):378-91
pubmed: 23566162
J Carcinog. 2013 Oct 09;12:19
pubmed: 24227994
Cancer Metastasis Rev. 2014 Sep;33(2-3):527-43
pubmed: 24398857
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
J Pathol. 2014 Jun;233(2):183-95
pubmed: 24623048
J Cell Physiol. 2015 Jan;230(1):16-26
pubmed: 24912145
Nat Mater. 2014 Oct;13(10):970-8
pubmed: 24930031
Anal Biochem. 2015 Mar 15;473:63-5
pubmed: 25542972
Adipocyte. 2015 Jan 07;4(2):89-100
pubmed: 26167413
Breast Cancer Res Treat. 2015 Sep;153(2):323-35
pubmed: 26285644
Sci Transl Med. 2015 Aug 19;7(301):301ra130
pubmed: 26290412
Breast Cancer (Auckl). 2015 Sep 01;9(Suppl 1):23-34
pubmed: 26380552
Oncotarget. 2015 Oct 27;6(33):34475-93
pubmed: 26439686
Breast Cancer Res. 2016 Jan 28;18(1):14
pubmed: 26821678
Sci Rep. 2016 Jun 03;6:27072
pubmed: 27255191
Obes Rev. 2016 Nov;17(11):1015-1029
pubmed: 27432523
Front Endocrinol (Lausanne). 2016 Jul 06;7:84
pubmed: 27458427
PLoS One. 2016 Aug 08;11(8):e0160615
pubmed: 27501241
SLAS Discov. 2017 Jun;22(5):456-472
pubmed: 28520521
Physiology (Bethesda). 2017 Jul;32(4):266-277
pubmed: 28615311
Cancer Cell. 2018 Apr 9;33(4):770-784.e6
pubmed: 29634950
Epithelial Cell Biol. 1993 Apr;2(2):79-89
pubmed: 8353596

Auteurs

Nikitha K Pallegar (NK)

Memorial University of Newfoundland, 232 Elizabeth Ave, St. Johns, NL, A1B 3X9, Canada.

Chantae J Garland (CJ)

Memorial University of Newfoundland, 232 Elizabeth Ave, St. Johns, NL, A1B 3X9, Canada.

Mathepan Mahendralingam (M)

Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, 50 Stone Road East, Guelph, ON, N1G 2W1, Canada.

Alicia M Viloria-Petit (AM)

Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, 50 Stone Road East, Guelph, ON, N1G 2W1, Canada. aviloria@uoguelph.ca.

Sherri L Christian (SL)

Memorial University of Newfoundland, 232 Elizabeth Ave, St. Johns, NL, A1B 3X9, Canada. sherri.christian@mun.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH